Back

TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI

30 August 2025 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Abdul Hakeem

National Institute of Cardiovascular Diseases (NICVD), Karachi (Pakistan)

3 More presentations in this session

Presentation thumbnail
The PARTHENOPE Trial: Personalized vs Standard DAPT after PCI
Associate Professor R. Piccolo (Naples, IT)
Slides Video
Presentation thumbnail
Device success in the Multivessel TALENT trial
Professor P. Serruys (Galway, IE)
Slides Video
Presentation thumbnail
APERITIF trial
Professor E. Puymirat (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions
31 August 2025
thumbnail
Congress Presentation
Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease
30 August 2025
thumbnail
Congress Presentation
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome
27 August 2022
thumbnail
Congress Presentation
Ticagrelor or prasugrel versus clopidogrel in patients with coronary heart disease
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources